1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid has been researched along with Carcinoma, Ductal, Pancreatic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andreae, F; Decristoforo, C; Helbok, A; Ocak, M; Radolf, T; Rangger, C; Virgolini, IJ; Von Guggenberg, E | 1 |
1 other study(ies) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Carcinoma, Ductal, Pancreatic
Article | Year |
---|---|
Design and evaluation of novel radiolabelled VIP derivatives for tumour targeting.
Topics: Animals; Binding, Competitive; Carcinoma, Pancreatic Ductal; Cells, Cultured; CHO Cells; Cricetinae; Drug Design; Female; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Peptide Fragments; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Vasoactive Intestinal Peptide; Tissue Distribution; Vasoactive Intestinal Peptide | 2013 |